Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia
Background: Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies with great variability in the pathogenesis and clinical course. DNA methylation of CpG islands within the promoters of specific genes may play roles in tumor initiation and progression. Secreted frizzled-re...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Vesnu Publications
2014-07-01
|
Series: | مجله دانشکده پزشکی اصفهان |
Subjects: | |
Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/3809 |
id |
doaj-7963c30bbdfa4d1ab8e6f4dad9ccfcee |
---|---|
record_format |
Article |
spelling |
doaj-7963c30bbdfa4d1ab8e6f4dad9ccfcee2020-11-25T00:11:02ZfasVesnu Publications مجله دانشکده پزشکی اصفهان1027-75951735-854X2014-07-01322867027111615Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic LeukemiaAli Ghasemi0Shahrbanoo Rostami1Nasrin Alizad-Ghandforosh2Abbas Ghotaslou3Sadegh Abbasian4Fatemeh Nadali5MSc Student, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology and Stem cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, IranMSc Student, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranMSc Student, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranMSc Student, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranAssociate Professor, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranBackground: Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies with great variability in the pathogenesis and clinical course. DNA methylation of CpG islands within the promoters of specific genes may play roles in tumor initiation and progression. Secreted frizzled-related proteins (SFRPs) are negative regulator of the Wnt signaling pathway. In the present study, we compared the methylation status of SFRP1 and SFRP2 genes promoter in patients with AML and healthy individuals. Methods: In peripheral blood from 43 patients afflicted with de novo AML and 25 healthy controls, isolated DNA was treated with sodium bisulfite and analyzed by methylation-specific polymerase chain reaction (MSP) with primers specific for methylated and unmethylated promoter sequences of the SFRP1 and SFRP2 genes. We used Mann-Whitney u-tests to investigate the correlation between SFRP1 and SFRP2 genes hypermethylation and clinical parameters. Findings: The frequency of aberrant hypermethylation of SFRP1 and SFRP2 genes promoter in patients with AML was determined 30.2% (13/43) and 20.9% (9/43), respectively. In addition, for all subjects in control group, methylation of SFRP1 and SFRP2 genes promoter were negative. Patients with M0 subtype of FAB-AML had the highest incidence of hypermethylation of SFRP1 (P = 0.028) and SFRP2 (P = 0.004) genes promoter. Conclusion: The present study showed that, like many solid tumors, SFRPs genes methylation also occurs in AML. Therefore, the methylation of these genes may play a role in leukemogenesis initiation.http://jims.mui.ac.ir/index.php/jims/article/view/3809Acute myeloblastic leukemiaSFRP geneDNA Methylation |
collection |
DOAJ |
language |
fas |
format |
Article |
sources |
DOAJ |
author |
Ali Ghasemi Shahrbanoo Rostami Nasrin Alizad-Ghandforosh Abbas Ghotaslou Sadegh Abbasian Fatemeh Nadali |
spellingShingle |
Ali Ghasemi Shahrbanoo Rostami Nasrin Alizad-Ghandforosh Abbas Ghotaslou Sadegh Abbasian Fatemeh Nadali Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia مجله دانشکده پزشکی اصفهان Acute myeloblastic leukemia SFRP gene DNA Methylation |
author_facet |
Ali Ghasemi Shahrbanoo Rostami Nasrin Alizad-Ghandforosh Abbas Ghotaslou Sadegh Abbasian Fatemeh Nadali |
author_sort |
Ali Ghasemi |
title |
Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia |
title_short |
Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia |
title_full |
Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia |
title_fullStr |
Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia |
title_full_unstemmed |
Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia |
title_sort |
study of sfrp1 and sfrp2 genes methylation status in patients with de novo acute myeloblastic leukemia |
publisher |
Vesnu Publications |
series |
مجله دانشکده پزشکی اصفهان |
issn |
1027-7595 1735-854X |
publishDate |
2014-07-01 |
description |
Background: Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies with great variability in the pathogenesis and clinical course. DNA methylation of CpG islands within the promoters of specific genes may play roles in tumor initiation and progression. Secreted frizzled-related proteins (SFRPs) are negative regulator of the Wnt signaling pathway. In the present study, we compared the methylation status of SFRP1 and SFRP2 genes promoter in patients with AML and healthy individuals.
Methods: In peripheral blood from 43 patients afflicted with de novo AML and 25 healthy controls, isolated DNA was treated with sodium bisulfite and analyzed by methylation-specific polymerase chain reaction (MSP) with primers specific for methylated and unmethylated promoter sequences of the SFRP1 and SFRP2 genes. We used Mann-Whitney u-tests to investigate the correlation between SFRP1 and SFRP2 genes hypermethylation and clinical parameters.
Findings: The frequency of aberrant hypermethylation of SFRP1 and SFRP2 genes promoter in patients with AML was determined 30.2% (13/43) and 20.9% (9/43), respectively. In addition, for all subjects in control group, methylation of SFRP1 and SFRP2 genes promoter were negative. Patients with M0 subtype of FAB-AML had the highest incidence of hypermethylation of SFRP1 (P = 0.028) and SFRP2 (P = 0.004) genes promoter.
Conclusion: The present study showed that, like many solid tumors, SFRPs genes methylation also occurs in AML. Therefore, the methylation of these genes may play a role in leukemogenesis initiation. |
topic |
Acute myeloblastic leukemia SFRP gene DNA Methylation |
url |
http://jims.mui.ac.ir/index.php/jims/article/view/3809 |
work_keys_str_mv |
AT alighasemi studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia AT shahrbanoorostami studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia AT nasrinalizadghandforosh studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia AT abbasghotaslou studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia AT sadeghabbasian studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia AT fatemehnadali studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia |
_version_ |
1725405485527465984 |